{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:48:39Z","timestamp":1786654119713,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IJC Heart & Vasculature"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ijcha.2026.101947","type":"journal-article","created":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T02:44:15Z","timestamp":1780454655000},"page":"101947","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Association between baseline left ventricular end-systolic diameter and one-year troponin response to tafamidis in transthyretin cardiac amyloidosis"],"prefix":"10.1016","volume":"65","author":[{"given":"Kei","family":"Morishita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2810-8040","authenticated-orcid":false,"given":"Eisuke","family":"Amiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junichi","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koki","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcha.2026.101947_b0005","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1001\/jamacardio.2024.5221","article-title":"Clinical phenotype and prognosis of asymptomatic patients with transthyretin cardiac amyloid infiltration","volume":"10","author":"Porcari","year":"2025","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcha.2026.101947_b0010","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1002\/ejhf.2606","article-title":"Progression of echocardiographic parameters and prognosis in transthyretin cardiac amyloidosis","volume":"24","author":"Chacko","year":"2022","journal-title":"Eur. J. Heart Fail."},{"issue":"4","key":"10.1016\/j.ijcha.2026.101947_b0015","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1253\/circj.CJ-24-0733","article-title":"Long-term effect of tafamidis on clinical parameters and prognostic predictors in patients with transthyretin amyloid cardiomyopathy","volume":"89","author":"Kuyama","year":"2025","journal-title":"Circ J"},{"key":"10.1016\/j.ijcha.2026.101947_b0020","doi-asserted-by":"crossref","unstructured":"Nakamura M, et al. Prognostic impact of the increase in cardiac troponin levels during tafamidis therapy in patients with transthyretin cardiac amyloidosis. J Clin Med. 2023;12(14):4631. Published 2023 Jul 12. doi:10.3390\/jcm12144631.","DOI":"10.3390\/jcm12144631"},{"key":"10.1016\/j.ijcha.2026.101947_b0025","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.124.034518","article-title":"Cardiac biomarker change at 1 year after tafamidis treatment and clinical outcomes in patients with transthyretin amyloid cardiomyopathy","volume":"13","author":"Kuyama","year":"2024","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2026.101947_b0030","doi-asserted-by":"crossref","first-page":"5049","DOI":"10.1093\/eurheartj\/ehaf412","article-title":"Transthyretin amyloid cardiomyopathy: natural history and treatment response assessed by cardiovascular magnetic resonance","volume":"46","author":"Patel","year":"2025","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcha.2026.101947_b0035","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.jacc.2024.03.394","article-title":"Small left ventricle in patients with atrial fibrillation is associated with increased cardiovascular risk","volume":"83","author":"Li","year":"2024","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcha.2026.101947_b0040","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019543","article-title":"Small left ventricle and clinical outcomes after transcatheter aortic valve replacement","volume":"10","author":"Saito","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcha.2026.101947_b0045","article-title":"Small heart size and premature death in 366,484 individuals with normal ejection fraction","volume":"4","author":"Rowe","year":"2024","journal-title":"JACC Adv."}],"container-title":["IJC Heart & Vasculature"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726000813?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352906726000813?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T20:23:51Z","timestamp":1786652631000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352906726000813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":9,"alternative-id":["S2352906726000813"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101947","relation":{},"ISSN":["2352-9067"],"issn-type":[{"value":"2352-9067","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between baseline left ventricular end-systolic diameter and one-year troponin response to tafamidis in transthyretin cardiac amyloidosis","name":"articletitle","label":"Article Title"},{"value":"IJC Heart & Vasculature","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcha.2026.101947","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101947"}}